The Argentine government's intervention in pharmaceutical pricing, particularly repeated price freezes, is both heavy handed and apparently open-ended. We have previously highlighted Argentina's highly challenging environment for pharmaceutical companies,, due to the anticipated future currency devaluation, high inflation and nationalisation approaches.
Argentina's biotechnology sector has become relatively competitive due to low-cost operations, high quality professionals, export-oriented policies, downsizing by multinationals and the expanding domestic market. More PPPs will boost the local industry to develop technology and production capabilities along the value chain, as Argentina lacks sufficient commercial funding and market mechanisms...
Complete the trial form to receive a free issue of Pharma and Healthcare Insight sent to your email address. The Pharma and Healthcare Insight provides you with in-depth country by country data, analysis and forecasts.
START A FREE TRIAL TODAY
STEP 2: SELECT PRODUCTS
Please select the free products you would like to trial:
Thank you for your interest in Pharma and Healthcare Insight
You will shortly receive an e-mail with link(s) to a full version of the newsletter(s) you selected. A member of our Client Services team will be in touch soon to receive your feedback on the newsletters and arrange a convenient time for a free demonstration of the full service. If your enquiry is urgent, please email our team here Thanks, BMI Research